UNITEDHEALTH GROUP INCORPORATED (Delaware) (UNH) Valuation
Historical valuation analysis based on 1281 data points (2021-09-10 to 2026-10-16)
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a lea...
UNITEDHEALTH GROUP INCORPORATED (Delaware) (UNH) currently trades at a P/E ratio of 25.51 (historical range: 10.20–40.61, median: 24.29), placing it at the 55th percentile — near its historical average, P/S ratio of 0.80 (range: 0.51–1.78, 23th percentile — below its historical average), EV/EBITDA of 18.69 (range: 8.60–23.53, 68th percentile).
UNITEDHEALTH GROUP INCORPORATED (Delaware) trades near its historical valuation range, with most metrics close to their median levels.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/E Ratio | 25.51 | 24.29 | 55th | near its historical average |
| P/S Ratio | 0.80 | 1.35 | 23th | below its historical average |
| EV/EBITDA | 18.69 | 17.67 | 68th | above its historical average |
| FCF Yield | 6.55% | 5.62% | 71th | below its historical average |
UNITEDHEALTH GROUP INCORPORATED (Delaware) (UNH) Valuation & P/E History
UNITEDHEALTH GROUP INCORPORATED (Delaware) (UNH) is a US-listed stock operating in the Healthcare sector, specifically the Healthcare Plans industry currently trading at $400.99 with a market capitalization of $359.9 billion. This page provides historical valuation analysis for UNH based on 1281 data points covering 2021-09-10 to 2026-10-16. The P/E ratio of 25.51 is above the historical median of 24.29, placing UNH at the 55th percentile of its valuation range. The P/S ratio of 0.80 compares to a median of 1.35.
UNH Valuation Metrics & Historical Range
The valuation table above shows UNITEDHEALTH GROUP INCORPORATED (Delaware)'s current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether UNH is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests UNH is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for UNITEDHEALTH GROUP INCORPORATED (Delaware).
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is UNH Overvalued or Undervalued?
UNITEDHEALTH GROUP INCORPORATED (Delaware) trades near its historical valuation range, with most metrics close to their median levels. The overall valuation percentile of 49 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive UNH is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full UNH analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.UNH trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.